CCRN Financial Statements

Balance sheet, income statement, cash flow, and dividends for Cross Country Healthcare Inc (CCRN).


$597.77M Market Cap.

As of 03/05/2025 5:00 PM ET (MRY) • Disclaimer

CCRN Market Cap. (MRY)


CCRN Shares Outstanding (MRY)


CCRN Assets (MRY)


Total Assets

$589.25M

Total Liabilities

$170.29M

Total Investments

$0

CCRN Income (MRY)


Revenue

$1.34B

Net Income

-$14.56M

Operating Expense

$291.12M

CCRN Cash Flow (MRY)


CF Operations

$120.12M

CF Investing

-$8.71M

CF Financing

-$46.85M

CCRN Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

CCRN Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$589,251,000 (-13.26%)

$679,317,000 (-28.33%)

$947,839,000 (29.34%)

$732,809,000 (105.28%)

Assets Current

$335,000,000 (-19.31%)

$415,153,000 (-38.56%)

$675,673,000 (32.94%)

$508,273,000 (177.58%)

Assets Non-Current

$254,251,000 (-3.75%)

$264,164,000 (-2.94%)

$272,166,000 (21.21%)

$224,536,000 (29.15%)

Goodwill & Intangible Assets

$177,246,000 (-6.66%)

$189,898,000 (-8.70%)

$207,991,000 (24.00%)

$167,734,000 (27.40%)

Shareholders Equity

$418,959,000 (-11.50%)

$473,393,000 (3.54%)

$457,219,000 (53.67%)

$297,528,000 (92.73%)

Property Plant & Equipment Net

$31,318,000 (4.61%)

$29,938,000 (30.64%)

$22,916,000 (-1.74%)

$23,321,000 (2.29%)

Cash & Equivalents

$81,633,000 (377.55%)

$17,094,000 (374.31%)

$3,604,000 (247.88%)

$1,036,000 (-35.25%)

Accumulated Other Comprehensive Income

-$1,441,000 (-4.04%)

-$1,385,000 (0.14%)

-$1,387,000 (-7.27%)

-$1,293,000 (-1.02%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$253,421,000 (-37.76%)

$407,163,000 (-39.42%)

$672,103,000 (34.70%)

$498,951,000 (185.60%)

Trade & Non-Trade Payables

$64,946,000 (-23.89%)

$85,333,000 (-54.00%)

$185,507,000 (69.02%)

$109,753,000 (120.05%)

Accumulated Retained Earnings (Deficit)

$218,059,000 (-8.52%)

$238,357,000 (43.83%)

$165,726,000 (828.95%)

-$22,735,000 (85.31%)

Tax Assets

$18,493,000 (43.89%)

$12,852,000 (-28.63%)

$18,007,000 (56.24%)

$11,525,000 (0%)

Tax Liabilities

$10,117,000 (-4.58%)

$10,603,000 (38.67%)

$7,646,000 (-53.09%)

$16,301,000 (146.98%)

Total Debt

$3,871,000 (-26.50%)

$5,267,000 (-96.66%)

$157,747,000 (-19.30%)

$195,485,000 (158.66%)

Debt Current

$2,089,000 (-19.78%)

$2,604,000 (-36.98%)

$4,132,000 (-50.01%)

$8,266,000 (19.21%)

Debt Non-Current

$1,782,000 (-33.08%)

$2,663,000 (-98.27%)

$153,615,000 (-17.95%)

$187,219,000 (172.75%)

Total Liabilities

$170,292,000 (-17.30%)

$205,924,000 (-58.03%)

$490,620,000 (12.71%)

$435,281,000 (115.42%)

Liabilities Current

$120,402,000 (-18.97%)

$148,587,000 (-45.30%)

$271,640,000 (35.98%)

$199,770,000 (113.83%)

Liabilities Non-Current

$49,890,000 (-12.99%)

$57,337,000 (-73.82%)

$218,980,000 (-7.02%)

$235,511,000 (116.78%)

CCRN Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$1,344,004,000 (-33.46%)

$2,019,728,000 (-28.04%)

$2,806,609,000 (67.39%)

$1,676,652,000 (100.46%)

Cost of Revenue

$1,069,752,000 (-31.83%)

$1,569,318,000 (-27.98%)

$2,178,923,000 (67.40%)

$1,301,653,000 (105.41%)

Selling General & Administrative Expense

$233,377,000 (-22.31%)

$300,391,000 (-7.35%)

$324,209,000 (50.59%)

$215,292,000 (23.87%)

Research & Development Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Expenses

$291,117,000 (-13.79%)

$337,697,000 (-4.76%)

$354,578,000 (50.44%)

$235,695,000 (11.23%)

Interest Expense

$2,188,000 (-72.97%)

$8,094,000 (-43.76%)

$14,391,000 (109.60%)

$6,866,000 (137.58%)

Income Tax Expense

-$1,842,000 (-106.09%)

$30,263,000 (-55.41%)

$67,864,000 (5527.20%)

$1,206,000 (741.49%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$14,556,000 (-120.04%)

$72,631,000 (-61.46%)

$188,461,000 (42.77%)

$132,002,000 (1187.15%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$14,556,000 (-120.04%)

$72,631,000 (-61.46%)

$188,461,000 (42.77%)

$132,002,000 (1118.38%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$14,556,000 (-120.04%)

$72,631,000 (-61.46%)

$188,461,000 (42.77%)

$132,002,000 (1118.38%)

Weighted Average Shares

$33,379,000 (-5.06%)

$35,158,000 (-5.01%)

$37,012,000 (0.88%)

$36,689,000 (1.67%)

Weighted Average Shares Diluted

$33,379,000 (-5.91%)

$35,476,000 (-5.49%)

$37,536,000 (0.39%)

$37,392,000 (3.61%)

Earning Before Interest & Taxes (EBIT)

-$14,210,000 (-112.80%)

$110,988,000 (-59.00%)

$270,716,000 (93.27%)

$140,074,000 (1465.24%)

Gross Profit

$274,252,000 (-39.11%)

$450,410,000 (-28.24%)

$627,686,000 (67.38%)

$374,999,000 (84.97%)

Operating Income

-$16,865,000 (-114.96%)

$112,713,000 (-58.73%)

$273,108,000 (96.05%)

$139,304,000 (1620.79%)

CCRN Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$8,714,000 (36.74%)

-$13,775,000 (68.60%)

-$43,874,000 (-28.87%)

-$34,046,000 (-637.72%)

Net Cash Flow from Financing

-$46,849,000 (78.82%)

-$221,241,000 (-152.56%)

-$87,599,000 (-173.55%)

$119,094,000 (641.09%)

Net Cash Flow from Operations

$120,116,000 (-51.66%)

$248,498,000 (85.38%)

$134,050,000 (256.57%)

-$85,618,000 (-414.73%)

Net Cash Flow / Change in Cash & Cash Equivalents

$64,539,000 (378.42%)

$13,490,000 (425.31%)

$2,568,000 (555.32%)

-$564,000 (-199.30%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

-$35,182,000 (-25.78%)

-$27,970,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$8,714,000 (37.64%)

-$13,974,000 (-59.05%)

-$8,786,000 (-22.54%)

-$7,170,000 (-55.36%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$150,675,000 (-291.35%)

-$38,501,000 (-131.67%)

$121,579,000 (705.68%)

Issuance (Purchase) of Equity Shares

-$37,310,000 (35.29%)

-$57,654,000 (-63.40%)

-$35,285,000 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$14,000 (-275.00%)

$8,000 (188.89%)

-$9,000 (-250.00%)

$6,000 (154.55%)

Share Based Compensation

$6,025,000 (-8.42%)

$6,579,000 (-11.01%)

$7,393,000 (7.24%)

$6,894,000 (27.60%)

Depreciation Amortization & Accretion

$19,192,000 (-1.37%)

$19,458,000 (34.88%)

$14,426,000 (17.51%)

$12,276,000 (-24.31%)

CCRN Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

20.40% (-8.52%)

22.30% (-0.45%)

22.40% (0.00%)

22.40% (-7.44%)

Profit Margin

-1.10% (-130.56%)

3.60% (-46.27%)

6.70% (-15.19%)

7.90% (626.67%)

EBITDA Margin

0.40% (-93.85%)

6.50% (-36.27%)

10.20% (12.09%)

9.10% (1200.00%)

Return on Average Equity (ROAE)

-3.30% (-121.15%)

15.60% (-65.94%)

45.80% (-23.79%)

60.10% (807.06%)

Return on Average Assets (ROAA)

-2.40% (-125.53%)

9.40% (-54.15%)

20.50% (-14.94%)

24.10% (769.44%)

Return on Sales (ROS)

-1.10% (-120.00%)

5.50% (-42.71%)

9.60% (14.29%)

8.40% (800.00%)

Return on Invested Capital (ROIC)

-5.50% (-120.37%)

27.00% (-35.10%)

41.60% (11.53%)

37.30% (831.37%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-41.27 (-477.37%)

10.94 (109.52%)

5.22 (-32.30%)

7.71 (131.30%)

Price to Sales Ratio (P/S)

0.45 (14.47%)

0.39 (12.57%)

0.35 (-42.34%)

0.61 (58.49%)

Price to Book Ratio (P/B)

1.43 (-15.11%)

1.68 (-22.43%)

2.17 (-38.89%)

3.55 (64.32%)

Debt to Equity Ratio (D/E)

0.41 (-6.67%)

0.43 (-59.46%)

1.07 (-26.66%)

1.46 (11.76%)

Earnings Per Share (EPS)

-0.44 (-121.26%)

2.07 (-59.33%)

5.09 (41.39%)

3.6 (1100.00%)

Sales Per Share (SPS)

40.27 (-29.91%)

57.45 (-24.24%)

75.83 (65.93%)

45.7 (97.17%)

Free Cash Flow Per Share (FCFPS)

3.34 (-49.98%)

6.67 (97.13%)

3.38 (233.81%)

-2.53 (-503.99%)

Book Value Per Share (BVPS)

12.55 (-6.78%)

13.46 (9.00%)

12.35 (52.34%)

8.11 (89.55%)

Tangible Assets Book Value Per Share (TABVPS)

12.34 (-11.34%)

13.92 (-30.36%)

19.99 (29.78%)

15.4 (146.67%)

Enterprise Value Over EBIT (EV/EBIT)

-38 (-642.86%)

7 (75.00%)

4 (-50.00%)

8 (120.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

108.02 (1689.60%)

6.04 (56.41%)

3.86 (-49.88%)

7.7 (-88.71%)

Asset Turnover

2.21 (-15.97%)

2.62 (-13.85%)

3.05 (-0.56%)

3.06 (33.12%)

Current Ratio

2.78 (-0.43%)

2.79 (12.34%)

2.49 (-2.24%)

2.54 (29.80%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$111,402,000 (-52.50%)

$234,524,000 (87.22%)

$125,264,000 (235.00%)

-$92,788,000 (-510.77%)

Enterprise Value (EV)

$538,153,310 (-31.65%)

$787,336,199 (-28.45%)

$1,100,357,505 (-6.18%)

$1,172,872,879 (188.69%)

Earnings Before Tax (EBT)

-$16,398,000 (-115.94%)

$102,894,000 (-59.86%)

$256,325,000 (92.42%)

$133,208,000 (1112.99%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$4,982,000 (-96.18%)

$130,446,000 (-54.25%)

$285,142,000 (87.16%)

$152,350,000 (2457.07%)

Invested Capital

$213,841,000 (-35.00%)

$329,005,000 (-47.14%)

$622,351,000 (11.18%)

$559,754,000 (171.90%)

Working Capital

$214,598,000 (-19.50%)

$266,566,000 (-34.02%)

$404,033,000 (30.97%)

$308,503,000 (243.97%)

Tangible Asset Value

$412,005,000 (-15.82%)

$489,419,000 (-33.85%)

$739,848,000 (30.93%)

$565,075,000 (150.79%)

Market Capitalization

$597,766,310 (-24.89%)

$795,815,199 (-19.69%)

$990,940,505 (-6.07%)

$1,054,981,879 (216.63%)

Average Equity

$437,725,500 (-6.13%)

$466,333,000 (13.27%)

$411,703,000 (87.34%)

$219,766,000 (43.59%)

Average Assets

$609,499,000 (-20.81%)

$769,681,750 (-16.47%)

$921,436,500 (68.36%)

$547,305,000 (50.57%)

Invested Capital Average

$256,156,000 (-37.65%)

$410,822,500 (-36.84%)

$650,457,250 (73.23%)

$375,492,750 (86.44%)

Shares

32,916,647 (-6.36%)

35,150,848 (-5.75%)

37,295,465 (-1.86%)

38,003,670 (1.17%)